BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16357133)

  • 1. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun.
    Bitomsky N; Böhm M; Klempnauer KH
    Oncogene; 2004 Sep; 23(45):7484-93. PubMed ID: 15334056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
    Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
    Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
    Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
    Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice.
    Hwang SK; Jin H; Kwon JT; Chang SH; Kim TH; Cho CS; Lee KH; Young MR; Colburn NH; Beck GR; Yang HS; Cho MH
    Gene Ther; 2007 Sep; 14(18):1353-61. PubMed ID: 17611588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.
    Wang Q; Zhang Y; Yang HS
    Biochim Biophys Acta; 2012 Oct; 1823(10):1807-14. PubMed ID: 22801218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.
    Zhen Y; Liu Z; Yang H; Yu X; Wu Q; Hua S; Long X; Jiang Q; Song Y; Cheng C; Wang H; Zhao M; Fu Q; Lyu X; Chen Y; Fan Y; Liu Y; Li X; Fang W
    Cell Death Dis; 2013 Oct; 4(10):e872. PubMed ID: 24157866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J; Sassano A; Hay N; Platanias LC
    Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells.
    Minet E; Michel G; Mottet D; Piret JP; Barbieux A; Raes M; Michiels C
    Exp Cell Res; 2001 Apr; 265(1):114-24. PubMed ID: 11281649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
    Jansen AP; Camalier CE; Colburn NH
    Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts.
    Gao A; Liu B; Shi X; Jia X; Ye M; Jiao S; You B; Huang C
    Toxicol Lett; 2007 Apr; 170(1):30-41. PubMed ID: 17383120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
    Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
    Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
    McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
    Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.